stonks4u
Sign up free
HCWB logo

HCWB HCW Biologics Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$2.68
-0.24 (-8.38%)

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patien…

Market Cap: $931.7Kwww.hcwbiologics.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 14Aug 14

Quote

Day Range
$2.58 – $3.25
52-Week Range
$1.50 – $44.10
Volume
$129.3K
Market Cap
$931.7K
50-Day Avg
$4.88
200-Day Avg
$7.02
Prev Close
$2.92
Open
$3.00

Valuation & Ratios

P/E Ratio
-0.09
EPS
$-22.77
P/B Ratio
0.74
P/S Ratio
37.52
Debt/Equity
2.46
Current Ratio
0.11
Dividend Yield
+0.0%
Gross Margin
+20.0%

Returns & Efficiency

Return on Equity
-287.9%
Return on Assets
-32.5%
FCF Yield
-658.1%
EV/EBITDA
-1.22

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$54.2K$-7.96M$-63.78
2024$2.57M$-30.02M$-4.62
2023$2.84M$-24.99M$-4.20
2022$6.72M$-14.90M$-2.52
2021$0.00$-12.86M$-2.16

Social Signal Score

50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $-1.08 per share

2of 6 quarters beat consensus

Typical surprise -275.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Aug 14$-11.58 vs $-1.98miss
  • Thu, May 14$2.22 vs $-2.64beat
  • Tue, Mar 31$-2.63 vs $-5.04beat
  • Fri, Nov 14$-4.13 vs $1.58miss
  • Mon, Aug 18$-40.74 vs $10.80miss
  • Fri, Mar 28$-3.20 vs $3.60miss

Estimates and results for HCWB via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

HCWBhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsglobenewswire.com·23h ago·Neutral

    …Clinical Development Highlights and Financial Results MIRAMAR, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, today reported financial results and recent business highlights for the three and six months ended June 30, 2026.

    View source ↗